Results 291 to 300 of about 73,410 (327)
Some of the next articles are maybe not open access.
Rheumatology International, 2016
We aimed to study the prevalence and clinical associations of myositis-specific autoantibodies (MSAs) and myositis-associated autoantibodies (MAAs) in a large cohort of Indian patients with idiopathic inflammatory myositis (IIM). Clinical details and serum samples were collected from patients with IIM (satisfying Bohan and Peter Criteria, 1975) and CTD-
Puja, Srivastava +2 more
openaire +2 more sources
We aimed to study the prevalence and clinical associations of myositis-specific autoantibodies (MSAs) and myositis-associated autoantibodies (MAAs) in a large cohort of Indian patients with idiopathic inflammatory myositis (IIM). Clinical details and serum samples were collected from patients with IIM (satisfying Bohan and Peter Criteria, 1975) and CTD-
Puja, Srivastava +2 more
openaire +2 more sources
Innere Medizin (Heidelberg, Germany), 2023
Extensive research work in the field of inflammatory myopathies over the past years has given us new insights into the classification and treatment of myositis. The myositis drug pipeline has never been stronger, although it is too early to know which products will eventually reach the market.
Stylianos, Tomaras, Eugen, Feist
openaire +1 more source
Extensive research work in the field of inflammatory myopathies over the past years has given us new insights into the classification and treatment of myositis. The myositis drug pipeline has never been stronger, although it is too early to know which products will eventually reach the market.
Stylianos, Tomaras, Eugen, Feist
openaire +1 more source
Myositis... Without the Myositis?
A32. CASES IN AUTOIMMUNITY, AUTOINFLAMMATION, AND INFECTION, 2023M.A. Dirico, A. Tahir, T. Zanders
openaire +1 more source
Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care
Nature Reviews Rheumatology, 2023Charalampia Papadopoulou +2 more
exaly
COVID-19 and Myositis: What We Know So Far
Current Rheumatology Reports, 2021Ahmad Saud, R Naveen, Rohit Aggarwal
exaly

